|
|
Blood, 15 December 2004, Vol. 104, No. 13, pp. 4210-4218.
Prepublished online as a Blood First Edition Paper on August 17, 2004; DOI 10.1182/blood-2004-01-0103.
 Previous Article | Table of Contents | Next Article 
NEOPLASIA
Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities
Guibin Chen,
Weihua Zeng,
Akira Miyazato,
Eric Billings,
Jaroslaw P. Maciejewski,
Sachiko Kajigaya,
Elaine M. Sloand, and
Neal S. Young
From the Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, MD.
Aneuploidy, especially monosomy 7 and trisomy 8, is a frequent cytogenetic abnormality in the myelodysplastic syndromes (MDSs). Patients with monosomy 7 and trisomy 8 have distinctly different clinical courses, responses to therapy, and survival probabilities. To determine disease-specific molecular characteristics, we analyzed the gene expression pattern in purified CD34 hematopoietic progenitor cells obtained from MDS patients with monosomy 7 and trisomy 8 using Affymetrix GeneChips. Two methods were employed: standard hybridization and a small-sample RNA amplification protocol for the limited amounts of RNA available from individual cases; results were comparable between these 2 techniques. Microarray data were confirmed by gene amplification and flow cytometry using individual patient samples. Genes related to hematopoietic progenitor cell proliferation and blood cell function were dysregulated in CD34 cells of both monosomy 7 and trisomy 8 MDS. In trisomy 8, up-regulated genes were primarily involved in immune and inflammatory responses, and down-regulated genes have been implicated in apoptosis inhibition. CD34 cells in monosomy 7 showed up-regulation of genes inducing leukemia transformation and tumorigenesis and apoptosis and down-regulation of genes controlling cell growth and differentiation. These results imply distinct molecular mechanisms for monosomy 7 and trisomy 8 MDS and implicate specific pathogenic pathways.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. K. Ahn, H.-S. Cha, E.-M. Koh, S.-H. Kim, Y. G. Kim, C.-K. Lee, and B. Yoo
Behcet's disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8
Rheumatology,
August 1, 2008;
47(8):
1228 - 1230.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Nilsson, P. Eden, E. Olsson, R. Mansson, I. Astrand-Grundstrom, B. Strombeck, K. Theilgaard-Monch, K. Anderson, R. Hast, E. Hellstrom-Lindberg, et al.
The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes
Blood,
October 15, 2007;
110(8):
3005 - 3014.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. Sloand, L. Pfannes, G. Chen, S. Shah, E. E. Solomou, J. Barrett, and N. S. Young
CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteins
Blood,
March 15, 2007;
109(6):
2399 - 2405.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Yuan, J. E. Payton, M. S. Holt, D. C. Link, M. A. Watson, J. F. DiPersio, and T. J. Ley
Commonly dysregulated genes in murine APL cells
Blood,
February 1, 2007;
109(3):
961 - 970.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Ganser, M. A. Morgan, and E. M. Weissinger
Going from genes to proteins in myelodysplastic syndromes
PNAS,
January 23, 2007;
104(4):
1109 - 1110.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. Sloand, A. S. M. Yong, S. Ramkissoon, E. Solomou, T. C. Bruno, S. Kim, M. Fuhrer, S. Kajigaya, A. J. Barrett, and N. S. Young
Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor
PNAS,
September 26, 2006;
103(39):
14483 - 14488.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Zeng, A. Miyazato, G. Chen, S. Kajigaya, N. S. Young, and J. P. Maciejewski
Interferon-{gamma}-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles
Blood,
January 1, 2006;
107(1):
167 - 175.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Sternberg, S. Killick, T. Littlewood, C. Hatton, A. Peniket, T. Seidl, S. Soneji, J. Leach, D. Bowen, C. Chapman, et al.
Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome
Blood,
November 1, 2005;
106(9):
2982 - 2991.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
